Skip to main content
    E

    Enovis Corp (ENOV)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $27.20
    -0.72 (-2.58%)

    Market Cap: $1.60B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Enovis Corp (ENOV) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Enovis (ENOV) has a market cap of $1.60B and an enterprise value of $2.90B. It kept -22.83% of revenue as net income over the last 12 months. Its net debt of $1.31B equals 81.73% of its market cap.

    Total Valuation

    Enterprise value is 81.73% above the market cap, as debt exceeds cash.

    Market Cap$1.60B
    Enterprise Value$2.90B
    Latest price (Nov 17, 2026)$27.20

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.04% in the quarter ended Sep 30, 2026 and grew 1.61% a year over 2 years.

    Shares Outstanding57.69M
    Shares Change (YoY)+0.88%
    Shares Change (QoQ)+0.04%
    Share Count Growth (2Y CAGR)+1.61%

    Valuation Ratios

    Sales and book value multiples are 0.7x and 1.1x. Its year-end P/E ranged from 5.2x to 23.6x from 2016 to 2025.

    P/E Ratio8.0x
    Forward P/E7.3x
    P/S Ratio0.7x
    Forward P/S0.7x
    P/B Ratio1.1x
    P/FCF Ratio22.6x
    P/OCF Ratio6.2x
    PEG Ratio1.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 41.3x free cash flow.

    EV / Sales1.3x
    EV / FCF41.3x

    Price Statistics

    The stock is down 9.30% over 52 weeks and trades 30.46% above its 50-day average.

    Beta (1Y)0.94
    52-Week Change-9.30%
    1-Month Change+36.89%
    3-Month Change+2.64%
    6-Month Change+5.59%
    5-Year Change-77.59%
    10-Year Change-63.61%
    Total Return (1Y)-9.30%
    Total Return (3Y CAGR)-19.02%
    Total Return (5Y CAGR)-20.90%
    Return vs SPY (1Y)-15.24%
    Max Drawdown (1Y)-44.53%
    Max Drawdown (3Y)-72.68%
    Sharpe Ratio (1Y)-0.06
    Correlation with SPY (1Y)0.19
    50-Day Average$20.85
    200-Day Average$23.29
    52-Week Range$16.70 to $31.67
    RSI (14 Days)63.4
    Average Volume (20 Days)1.84M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.15x current liabilities, and total debt is 0.88x shareholder equity.

    Current Ratio2.15x
    Quick Ratio1.08x
    Debt / Equity0.88x
    Debt / FCF18.95x
    Interest Coverage-14.52x

    Returns and Efficiency

    Return on invested capital is -16.70% over the last 12 months, against a 5-year average of -12.49%.

    Return on Equity (ROE)-35.26%
    Return on Assets (ROA)-14.09%
    Return on Invested Capital (ROIC)-16.70%
    Return on Capital Employed (ROCE)-14.88%
    ROE (5Y Average)-22.26%
    ROA (5Y Average)-9.69%
    ROIC (5Y Average)-12.49%
    Asset Turnover0.56x
    Inventory Turnover1.46x
    Receivables Turnover5.30x
    Cash Conversion Cycle238 days

    Scores

    ENOV has an Altman Z-Score of 0.28, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score0.28
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $2.31B over the last 12 months is up 3.28% from the 12 months before.

    Revenue$2.31B
    Revenue Growth (YoY)+3.28%
    Gross Profit$1.41B
    Operating Income-$474.86M
    Pretax Income-$501.90M
    Net Income-$526.52M
    EBITDA-$174.67M
    EBIT-$469.57M
    Reported EPS (TTM)$3.38

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 39.84% of the $3.74B in total assets.

    Cash and Equivalents$13.04M
    Total Debt$1.32B
    Net Debt$1.31B
    Net Debt Per Share$22.62
    Working Capital$667.74M
    Shareholder Equity$1.49B
    Book Value Per Share$25.88
    Tangible Book Value-$302.79M
    Total Assets$3.74B
    Total Liabilities$2.24B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $189.46M of capital spending, operating cash flow left $69.56M of free cash flow.

    Operating Cash Flow$259.02M
    Capital Expenditures$189.46M
    Free Cash Flow$69.56M
    FCF Per Share$1.21
    Depreciation and Amortization$294.90M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -20.59%, against a 5-year average of -19.92%.

    Gross Margin61.31%
    Operating Margin-20.59%
    Pretax Margin-21.76%
    Net Margin-22.83%
    EBITDA Margin-7.57%
    EBIT Margin-20.36%
    FCF Margin3.02%
    Gross Margin (5Y Average)56.81%
    Operating Margin (5Y Average)-19.92%
    Net Margin (5Y Average)-17.82%

    Growth

    Revenue grew 12.88% a year over 3 years, and EPS 13.28% a year.

    Revenue Growth (3Y CAGR)+12.88%
    Revenue Growth (5Y CAGR)+14.94%
    EPS Growth (3Y CAGR)+13.28%
    EPS Growth (5Y CAGR)-4.57%
    FCF Growth (5Y CAGR)-36.11%
    Book Value Per Share Growth (2Y CAGR)-35.28%

    Revenue and profit by year

    Dividends and Yields

    ENOV does not pay a dividend. Its free cash flow yield is 4.43%.

    Earnings Yield12.50%
    FCF Yield4.43%
    Buyback Yield-0.09%
    Shareholder Yield-0.09%

    Stock Splits

    The last reverse split was on Apr 5, 2022.

    Last Split DateApr 5, 2022
    Split TypeReverse split

    Peer Position

    Against 6 similar companies, ENOV has the 6th highest P/E.

    P/E Ratio8.0x vs 30.7x median
    P/S Ratio0.7x vs 2.3x median
    ROIC-16.70% vs -3.43% median
    Revenue Growth (Trailing 4 Quarters, YoY)+3.28% vs +11.95% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 4.34% and EPS growth at 2.45% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+4.34%
    EPS Growth Forecast (2Y CAGR)+2.45%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ENOV

    What is ENOV's market cap?

    Enovis has a market cap of $1.60B. Its enterprise value, which adds debt and subtracts cash, is $2.90B.

    What is ENOV's P/E ratio?

    Enovis has a trailing P/E ratio of 8.0x and a forward P/E of 7.3x.

    How many shares of ENOV are outstanding?

    Enovis has 57.69M shares outstanding. The count is up 0.88% from a year earlier.

    Does ENOV pay a dividend?

    No. Enovis does not pay a dividend.

    How much debt does ENOV have?

    Enovis has $1.32B of total debt and $13.04M of cash and equivalents, a net debt position of $1.31B.